Sinopharm
1099.HK
#2044
Rank
NZ$13.41 B
Marketcap
$4.45
Share price
-1.46%
Change (1 day)
7.45%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

P/S ratio for Sinopharm (1099.HK)

P/S ratio at the end of 2022: 0.0992

According to Sinopharm's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4603. At the end of 2022 the company had a P/S ratio of 0.0992.

P/S ratio history for Sinopharm from 2009 to 2022

PS ratio at the end of each year

Year P/S ratio Change
20220.099219.55%
20210.0830-19.48%
20200.1031-42.19%
20190.1783-28.45%
20180.2492-1.5%
20170.2530-17.5%
20160.3067-2.56%
20150.31473.88%
20140.303013.36%
20130.2673-22.15%
20120.3433-3.19%
20110.3546-52.91%
20100.7532-27.82%
20091.04